Gastrin and colorectal cancer: cause or consequence?
Seitz, J.F.; Monges, G.; Giovannini, M.
Gastroenterologie Clinique et Biologique 16(12): 1009-1010
1992
ISSN/ISBN: 0399-8320 PMID: 1493890 Document Number: 398174
Document emailed within 1 workday
Related Documents
Charnley, R.M.; Thomas, W.M.; Stanley, J.; Morris, D.L. 1992: Serum gastrin concentrations in colorectal cancer patients Annals of the Royal College of Surgeons of England 74(2): 138-40; Discussion 141Khalturin, V.I.; Gamaiunova, V.B.; Mel'nikov, R.A.; Bershteĭn, L.M. 1994: Features of blood gastrin in patients with colorectal cancer: possible prognostic significance Voprosy Onkologii 40(1-3): 50-53
Schmitz, F.; Schmidt, W.E. 1998: Is gastrin trophic? Gastrin/ gastrin receptor "knockout" mice confirm the old hypothesis Zeitschrift für Gastroenterologie 36(7): 613-616
Imdahl, A.; Michalski, Y.; Eggstein, S.; Strik, M.; Farthmann, E.H. 1992: Serum gastrin level in patients with colorectal adenoma or carcinoma Zentralblatt für Chirurgie 117(8): 439-443
Kaufmann, H.P.; Ottenjann, R. 1991: Fasting blood gastrin levels in colon adenomas and colorectal carcinomas Zeitschrift für Gastroenterologie 29(10): 527-528
Aaltonen, L.A.; Sankila, R.; Mecklin, J.P.; Järvinen, H.; Pukkala, E.; Peltomäki, P.; de la Chapelle, A. 1994: A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden Cancer Detection and Prevention 18(1): 57-63
Mao, J.-d.; Wu, P.; Yang, Y.-l.; Wu, J.; Hu, J.-q.; Huang, H. 2008: Relationships of the mRNA and protein expression of gastrin with Fas/FasL and caspases in colorectal carcinoma Zhonghua Wei Chang Wai Ke Za Zhi 11(6): 554-557
Cerea, G.; Vaghi, M.; Ardizzoia, A.; Villa, S.; Bucovec, R.; Mengo, S.; Gardani, G.; Tancini, G.; Lissoni, P. 2003: Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations Anticancer Research 23(2c): 1951-1954
Ishida, H.; Fujioka, M.; Ohsawa, T.; Takeuchi, I.; Nakada, H.; Ishizuka, N.; Yokoyama, M.; Inokuma, S.; Yamada, H.; Odaka, A.; Hoshino, T.; Murata, N.; Hashimoto, D.; Matsumoto, Y.; Miura, T. 2001: Effect of peroral doxifluridine plus hepatic arterial infusion for synchronous liver metastasis of colorectal cancer--correlation with the expression of thymidine phosphorylase and dihydropyrimidine dehydrogenase in primary colorectal cancer lesions Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(11): 1624-1627
Asnaes, S.; Bijerregaard, B.; Malmström, M.; Hansen, O.H.; Hardt, F.; Johansen, A. 1976: Antral gastrin cells. a correlation between the number of gastrin cells and the total concentration of gastrin in serum and in antral mucosa. a pilot investigation Scandinavian Journal of Gastroenterology 11(5): 471-474
Beuran, M.; Chiotoroiu, A.L.; Chilie, A.; Morteanu, S.; Vartic, M.; Avram, M.; Roşu, O.; Lică, I. 2010: Stapled vs. hand-sewn colorectal anastomosis in complicated colorectal cancer--a retrospective study Chirurgia 105(5): 645-651
Vagliasindi, A.; Sivelli, R.; Gualtierotti, M.; Piccolo, D.; Bertagni, A.; Sianesi, M. 2003: Are small-size depressed-type colorectal neoplasias really the expression of a early stage of colorectal cancer. Apropos of a clinical case Tumori 89(4 Suppl): 155-158
Mishchuk, V.G.; Shutka, B.V. 1991: Blood gastrin and ultrastructure of gastrin-producing cells in chronic gastritis with secretory insufficiency Vrachebnoe Delo 6: 61-63
Reichle, F.A.; Reeder, D.D.; Reichle, R.M.; Thompson, J.C. 1974: Serum gastrin, gastrointestinal tissue gastrin, gastric hypersecretion after portacaval shunt in rats Surgical Forum 25(0): 418-420
Penn, I. 1988: Secondary neoplasms as a consequence of transplantation and cancer therapy Cancer Detection and Prevention 12(1-6): 39-57
Salupere, R.V.; Uibo, R.M.; Tsil'mer, K.I. 1986: Gastrin cells and the basal level of serum gastrin in patients with insulin-dependent diabetes mellitus Terapevticheskii Arkhiv 58(2): 13-15
Kanczuga-Koda, L.; Koda, M.; Sulkowski, S.; Wincewicz, A.; Zalewski, B.; Sulkowska, M. 2010: Gradual loss of functional gap junction within progression of colorectal cancer -- a shift from membranous CX32 and CX43 expression to cytoplasmic pattern during colorectal carcinogenesis In Vivo 24(1): 101-107
Zou, Y.-f.; Cai, Z.-r.; Chen, Y.-f.; Rong, Y.-m.; Wu, X.-r.; Yuan, R.-x.; He, X.-s.; Wu, X.-j.; Lan, P. 2013: Comparison of local immune microenvironment between liver-metastasis colorectal cancer and non-liver-metastasis colorectal cancer Zhonghua Wei Chang Wai Ke Za Zhi 16(6): 547-551
Kozuszko, B.; Skrzydlewski, Z.; Sulkowska, M.; Snarska, J.; Kozłowski, M.; Skrzydlewska, E.; Zalewski, B. 2001: Cancer procoagulant activity in cases of esophageal, stomach and colorectal cancer considering progression degree and histological type of cancer Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 11(63): 218-220
Gil-Ad, I.; Zolokov, A.; Lomnitski, L.; Taler, M.; Bar, M.; Luria, D.; Ram, E.; Weizman, A. 2008: Evaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted mice International Journal of Oncology 33(2): 277-286